The BAD apoptotic pathway: a cervical cancer therapeutic target associated with disease development, therapeutic response and patient survival

Bush, Stephen

361
The BAD apoptotic pathway: a cervical cancer therapeutic target associated with disease development, therapeutic response and patient survival

Sunday, March 29, 2015: 7:00 AM

Salon C-D (Hilton Chicago)

S. H. Bush¹, D. Marchion², Y. Xiong², F. Abbasi², A. Berry¹, H. S. Chon², M. M. K. Shahzad², S. M. Apte², R. M. Wenham², P. Judson¹ and J. M. Lancaster²
¹H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL, ²H. Lee Moffitt Cancer Center, Tampa, FL

2015 Annual Meeting on Women's Cancer®

March 26 - 31, 2015

Navigation

361
The BAD apoptotic pathway: a cervical cancer therapeutic target associated with disease development, therapeutic response and patient survival

361 The BAD apoptotic pathway: a cervical cancer therapeutic target associated with disease development, therapeutic response and patient survival

361
The BAD apoptotic pathway: a cervical cancer therapeutic target associated with disease development, therapeutic response and patient survival